Annual Report 2008 - 2009 - Liverpool School of Tropical Medicine
Annual Report 2008 - 2009 - Liverpool School of Tropical Medicine
Annual Report 2008 - 2009 - Liverpool School of Tropical Medicine
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
DISEASE CONTROL STRATEGY GROUP<br />
...a public–private partnership, the<br />
Global Programme to Eliminate<br />
Lymphatic Filariasis, whose<br />
secretariat is at the <strong>Liverpool</strong><br />
<strong>School</strong> <strong>of</strong> <strong>Tropical</strong> <strong>Medicine</strong>, UK,<br />
is now bringing vital drugs<br />
to 570 million people in 48<br />
countries annually<br />
(Nature <strong>2009</strong>; 457, 772.)<br />
Pr<strong>of</strong>essor David Molyneux<br />
David Molyneux, successfully defended his<br />
PhD thesis on ‘Lymphatic filariasis in Zanzibar:<br />
Epidemiology, elimination and impact’.<br />
Pr<strong>of</strong>essor David Molyneux as a member <strong>of</strong> the<br />
International Commission for the Certification<br />
for the Eradication <strong>of</strong> Guinea Worm led a team<br />
<strong>of</strong> WHO staff and consultants to Mauritania in<br />
January to investigate if transmission <strong>of</strong> Guinea<br />
Worm had ceased in this vast desert country. The<br />
results demonstrated that Mauritania appears<br />
to be free <strong>of</strong> the disease and represents another<br />
country on the increasing list <strong>of</strong> countries<br />
certified free <strong>of</strong> this debilitating condition.<br />
Two collaborative grant proposals were<br />
funded during the academic year, including<br />
a US$34m award to the Global Network for<br />
Neglected <strong>Tropical</strong> Diseases (GNNTD) from the<br />
Bill & Melinda Gates Foundation to mobilise<br />
US$200m in support <strong>of</strong> the NTD elimination/<br />
control programmes. Since the award late last<br />
year GNNTD has been working diligently with<br />
CNTD and other global partners to develop a<br />
strategic plan on how this can be developed<br />
and the goal achieved.<br />
DFID and GlaxoSmithKline (GSK) continued<br />
their support to CNTD for co-ordinating the<br />
activities <strong>of</strong> the Global Alliance to Eliminate<br />
Lymphatic Filariasis (GAELF). GAELF supports<br />
the Global Programme to Eliminate Lymphatic<br />
Filariasis (GPELF). Along with the 30 plus NTD<br />
partners in the alliance, it has added value at<br />
16 LSTM ANNUAL REPORT